National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United S…
$26.33-0.87%
报价 2026-11-16
市值
$558.8M
EV
$698.1M
PE (TTM)
89.5x
预期 PE (FY2026)
19.2x
52 周区间距高点 -2.7%
$12.03$27.07
筛选结果
pipeline · 2026-11-16Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-16未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 0.9x | 1.08 → 1.11(1.0x) | 23.7 |
| FY+32028-12 | 0.9x | 1.08 → 1.16(1.1x) | 22.7 |
毛利率 48% · TTM 收入 $144M · 基数 EPS 1.08(调整后)
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| NRCNational Research Corporation | $558.8M | -0.9% | +6.5% | 47.9% | 89.5x | 28.5x | 32.5x | |
| SOPHSOPHiA GENETICS S.A. | $633.4M | -9.4% | – | 67.3% | – | – | – | |
| PBYIPuma Biotechnology, Inc. | $379.5M | -5.5% | +2.0% | 74.5% | 10.1x | 5.4x | 26.3x | |
| VMDViemed Healthcare, Inc. | $346.7M | -0.2% | +16.9% | 57% | 23.4x | 6.9x | 16.2x | GARP |
| SPOKSpok Holdings, Inc. | $245.4M | +0.7% | -0.9% | 88.5% | 13.2x | 7.1x | 8.2x | |
| DHDefinitive Healthcare Corp. | $135M | -3.8% | -6.7% | 71.7% | – | – | 4.1x | |
| QTRXQuanterix Corporation | $134.8M | -3.1% | +27.6% | 41.7% | – | – | – | |
| HCATHealth Catalyst, Inc. | $105.1M | -8.6% | -13.6% | 46.4% | – | – | 9.2x | |
| NNOXNano-X Imaging Ltd. | $25.2M | -0.6% | – | -338.2% | – | – | – | |
| 同行中位数 | – | – | +0.6% | 62.1% | 13.2x | 6.9x | 9.2x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。